Announcements
On x'x'x, 2025, the company announced on the Hong Kong Stock Exchange that it plans to globally issue x'x'x'x shares, including x'x'x Hong Kong shares, x'x'x international shares, and an additional x'x% over-allotment option.
Quick Links
With deep roots in China and a global vision, we have established end-to-end capabilities from radionuclide development and production, radiopharmaceutical research and development, to radiopharmaceutical manufacturing and commercialization.
Corporate Governance
Investor Calendar
Presentations
IR mail
ir@sinotau.com